RWE Solutions
Panalgo is now a full-service analytics solutions provider, offering our industry leading IHD Analytics software, analytic services, and now streamlined access to data through industry partnerships to give our customers a truly differentiated, personalized, and integrated RWE solution.
Our RWE Solutions
Streamlined Access to Data
- Streamlined access to a wealth of real-world data from our network of industry partnerships
- Get industry-leading data sources at your fingertips within IHD or through analytics services
- Data sources include laboratory, open claims, closed claims, EHR, Registry, and Other
- Panalgo Partner Data Assets can be linked with existing data files from other data providers and partners - offering a unique and bespoke data asset to fit your needs
Industry-Leading Technology
- Instant Health Data (IHD) Analytics
- Self-service, RWE platform
- Analysis-ready datasets
- Full scale analyses completed in days or weeks vs. months
- Speed, flexibility, efficiency, quality, and transparency of results
- Report Collaboration Module enables instant sharing of results via custom dashboards
- IHD Data Science Module provides machine learning to bring a predictive lens to your analyses
Expert Analytic Services
- Insights as a Service (IaaS): Analysts integrated into your team, powered by IHD
- Study Seat: Link IaaS with full-service consulting partners
- Support+: Custom analytics hourly support bundles
Your Partner on the Analytics Journey
We are guides on your journey – providing you with maps to help plan and prioritize your research agendas.
We are fuel on your journey – making data accessible and providing software to complete your analytics projects across the clinical and commercial life cycle.
We ride-along on your journey – with our expert analysts driving when you need a break.
Leverage RWD across the product life cycle with one end-to-end RWE solution.
Streamlined Access to Data
Open Claims
Norstella RWD
- 300M+ patients
- Channel representation of commercial, Medicaid, Medicare, and other government coverage. 6+ years of longitudinal patient data.
- 2.1M HCPs
- 7,000 hospitals, 1,500 ACOs, 5,600 health systems, and 6.5 million affiliations
- 98% of payers
Closed Claims
Panalgo Data Partner
- US, Multi-Therapeutic, Multi-Payor database with 10 years of patient history.
- Commercial, Medicaid, and Medicare Advantage – 220M+ total lives.
- Fully adjudicated closed claims – medical, RX, and all sites of care.
- Enrollment ensures fewer gaps in patient journey.
- Provider information alongside financial information when available.
Laboratory
Norstella
- 275 million US lives and 200 million lab patients with linked claims
- 30 billion clinical transactions
- 500 million diagnostic test results per month
- 200 million test results from in-patient hospitals
- Data from top 3 out of 4 commercial reference labs, several regional labs, and over 100 hospitals and health systems
EHR
TriNetX Global Network and DataWorks
- Aggregated counts of patients, providers, sites/facilities, prescriptions, procedures for: 185M patients, 147 Healthcare Organizations, and 18 countries.
- Extract available at the transactional record level to build custom cohorts: 100M+ Dataworks EHR and 7.5M+ US EHR+Claims data available for extract applications.
Industry-Leading Technology
Panalgo’s Instant Health Data (IHD) Analytics platform is the leading healthcare analytics solution for the life sciences industry. This RWE, SaaS, self-service platform streamlines the analytics process by removing complex programming from the equation and allowing you to focus on what matters most – turning data into insights.
Transparent and trustworthy
Collaborative
Intuitive and flexible
See what Panalgo can do for you
Early Phases
Research & Development
- Quantify burden of diseases
- Optimize clinical trial design
- Identify opportunities for label expansion
- Profile target populations and understand market potential
- Identify clinical trial sites, investigators, and enrollment criteria
- Ensure diversity of patients in clinical trials
Epidemiology
- Assess benefits and risks
- Evaluate incidence and prevalence
- Conduct feasibility studies
- Understand natural history of disease
Late Phases & Post Approval
Epidemiology
- Rapidly respond to regulators
- Evaluate drug safety and effectiveness
- Evaluate treatment patterns
- Monitor imposed guidelines (e.g. dosing/duration)
- Compliance with mandatory and voluntary post-market commitments (such as long-term follow-up, pediatric, or pregnancy studies)
HEOR
- Analyze comparative effectiveness
- Determine healthcare resource use and cost
- Understand patient outcomes
- Evaluate adherence and drug utilization
- Generate evidence for market access and reimbursement
- Develop value-based contracts
- Support payor conversations
- Continued assessment of product safety, effectiveness, and value
Payor
- Understand population benchmarks and trends such as course of care and cost
- Improve care management program design through evaluation
- Inform benefit design, value-based care models, and formulary decisions
- Evaluate provider / network performance such as treatment prescription patterns and outcomes